151 related articles for article (PubMed ID: 24606940)
1. Molecular analysis of the interaction between staphylococcal virulence factor Sbi-IV and complement C3d.
Gorham RD; Rodriguez W; Morikis D
Biophys J; 2014 Mar; 106(5):1164-73. PubMed ID: 24606940
[TBL] [Abstract][Full Text] [Related]
2. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.
Isenman DE; Leung E; Mackay JD; Bagby S; van den Elsen JM
J Immunol; 2010 Feb; 184(4):1946-55. PubMed ID: 20083651
[TBL] [Abstract][Full Text] [Related]
3. A structural basis for Staphylococcal complement subversion: X-ray structure of the complement-binding domain of Staphylococcus aureus protein Sbi in complex with ligand C3d.
Clark EA; Crennell S; Upadhyay A; Zozulya AV; Mackay JD; Svergun DI; Bagby S; van den Elsen JM
Mol Immunol; 2011 Jan; 48(4):452-62. PubMed ID: 21055811
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus.
Burman JD; Leung E; Atkins KL; O'Seaghdha MN; Lango L; Bernadó P; Bagby S; Svergun DI; Foster TJ; Isenman DE; van den Elsen JM
J Biol Chem; 2008 Jun; 283(25):17579-93. PubMed ID: 18434316
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi.
Upadhyay A; Burman JD; Clark EA; Leung E; Isenman DE; van den Elsen JM; Bagby S
J Biol Chem; 2008 Aug; 283(32):22113-20. PubMed ID: 18550524
[TBL] [Abstract][Full Text] [Related]
6. Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.
Shaw CD; Storek MJ; Young KA; Kovacs JM; Thurman JM; Holers VM; Hannan JP
J Mol Biol; 2010 Dec; 404(4):697-710. PubMed ID: 20951140
[TBL] [Abstract][Full Text] [Related]
7. A theoretical view of the C3d:CR2 binding controversy.
Mohan RR; Gorham RD; Morikis D
Mol Immunol; 2015 Mar; 64(1):112-22. PubMed ID: 25433434
[TBL] [Abstract][Full Text] [Related]
8. Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant.
Yang Y; Back CR; Gräwert MA; Wahid AA; Denton H; Kildani R; Paulin J; Wörner K; Kaiser W; Svergun DI; Sartbaeva A; Watts AG; Marchbank KJ; van den Elsen JMH
Front Immunol; 2018; 9():3139. PubMed ID: 30687332
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal Complement Evasion Protein Sbi Stabilises C3d Dimers by Inducing an N-Terminal Helix Swap.
Dunphy RW; Wahid AA; Back CR; Martin RL; Watts AG; Dodson CA; Crennell SJ; van den Elsen JMH
Front Immunol; 2022; 13():892234. PubMed ID: 35693766
[No Abstract] [Full Text] [Related]
10. Electrostatic exploration of the C3d-FH4 interaction using a computational alanine scan.
El-Assaad AM; Kieslich CA; Gorham RD; Morikis D
Mol Immunol; 2011 Sep; 48(15-16):1844-50. PubMed ID: 21683447
[TBL] [Abstract][Full Text] [Related]
11. The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands.
Giussani S; Pietrocola G; Donnarumma D; Norais N; Speziale P; Fabbrini M; Margarit I
FASEB J; 2019 Mar; 33(3):4448-4457. PubMed ID: 30566365
[TBL] [Abstract][Full Text] [Related]
12. Immunophysical exploration of C3d-CR2(CCP1-2) interaction using molecular dynamics and electrostatics.
Zhang L; Mallik B; Morikis D
J Mol Biol; 2007 Jun; 369(2):567-83. PubMed ID: 17434528
[TBL] [Abstract][Full Text] [Related]
13. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
Haupt K; Reuter M; van den Elsen J; Burman J; Hälbich S; Richter J; Skerka C; Zipfel PF
PLoS Pathog; 2008 Dec; 4(12):e1000250. PubMed ID: 19112495
[TBL] [Abstract][Full Text] [Related]
14. Electrostatic Steering Accelerates C3d:CR2 Association.
Mohan RR; Huber GA; Morikis D
J Phys Chem B; 2016 Aug; 120(33):8416-23. PubMed ID: 27092816
[TBL] [Abstract][Full Text] [Related]
15. Multi-scale characterization of the energy landscape of proteins with application to the C3D/Efb-C complex.
Haspel N; Geisbrecht BV; Lambris J; Kavraki L
Proteins; 2010 Mar; 78(4):1004-14. PubMed ID: 19899169
[TBL] [Abstract][Full Text] [Related]
16. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2.
Nagar B; Jones RG; Diefenbach RJ; Isenman DE; Rini JM
Science; 1998 May; 280(5367):1277-81. PubMed ID: 9596584
[TBL] [Abstract][Full Text] [Related]
17. Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.
Haspel N; Ricklin D; Geisbrecht BV; Kavraki LE; Lambris JD
Protein Sci; 2008 Nov; 17(11):1894-906. PubMed ID: 18687868
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanism of pH-regulating C3d-CR2 interactions: Insights from molecular dynamics simulation.
Zhang Y; Guo J; Ning L; Tian J; Yao X; Liu H
Chem Biol Drug Des; 2019 Apr; 93(4):628-637. PubMed ID: 30566277
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.
Ricklin D; Ricklin-Lichtsteiner SK; Markiewski MM; Geisbrecht BV; Lambris JD
J Immunol; 2008 Dec; 181(11):7463-7. PubMed ID: 19017934
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d.
Wan H; Hu JP; Tian XH; Chang S
Phys Chem Chem Phys; 2013 Jan; 15(4):1241-51. PubMed ID: 23229122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
